Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nazanin K Majd

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Current Oncology (Toronto, Ont.)|June 27, 2023
The Role of Immunotherapy in the Treatment of Rare Central Nervous System TumorsAndrew Rodriguez, Carlos Kamiya-Matsuoka, Nazanin K Majd
Advances in Experimental Medicine and Biology|January 1, 2022
Immunotherapy for Neuro-oncologyNazanin K Majd, Pushan R Dasgupta, John F de Groot
Cancers|February 11, 2023
Preclinical Models of Low-Grade GliomasPushan Dasgupta, Veerakumar Balasubramanyian, John F de Groot, et al.
Advances in Experimental Medicine and Biology|January 1, 2022
Neurologic Toxicities of ImmunotherapyRebecca A Harrison, Nazanin K Majd, Sudhakar Tummala, et al.
JCO Precision Oncology|February 23, 2024
Therapeutic Strategies for Gliomas Associated With Cancer Predisposition SyndromesKeng Lam, Carlos Kamiya-Matsuoka, John M Slopis, et al.
Journal of Immunotherapy and Precision Oncology|May 22, 2023
Recent Therapeutic Advances in Pituitary CarcinomaIan J Robertson, Timothy A Gregory, Steven G Waguespack, et al.
Cancer|May 25, 2023
Characterization of industry relationships in oncologyRebecca A Harrison, Nazanin K Majd, Margaret O Johnson, et al.
Journal of Pediatric Hematology/Oncology|September 26, 2012
Total skin electron beam radiation in a pediatric patient with leukemia cutis: a case reportNazanin K Majd, Sheena K Jain, Mike C Murphy, et al.
Journal of Gastrointestinal Oncology|July 11, 2024
Intrathecal topotecan with systemic checkpoint inhibitor therapy for gastroesophageal cancer with leptomeningeal involvement: two case reports and review of the literatureCindy M Pabon, Debra N Yeboa, Barbara J O'Brien, et al.
Neuro-Oncology Advances|March 19, 2021
The promise of DNA damage response inhibitors for the treatment of glioblastomaNazanin K Majd, Timothy A Yap, Dimpy Koul, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Current Oncology (Toronto, Ont.)|June 27, 2023
The Role of Immunotherapy in the Treatment of Rare Central Nervous System TumorsAndrew Rodriguez, Carlos Kamiya-Matsuoka, Nazanin K Majd
Advances in Experimental Medicine and Biology|January 1, 2022
Immunotherapy for Neuro-oncologyNazanin K Majd, Pushan R Dasgupta, John F de Groot
Cancers|February 11, 2023
Preclinical Models of Low-Grade GliomasPushan Dasgupta, Veerakumar Balasubramanyian, John F de Groot, et al.
Advances in Experimental Medicine and Biology|January 1, 2022
Neurologic Toxicities of ImmunotherapyRebecca A Harrison, Nazanin K Majd, Sudhakar Tummala, et al.
JCO Precision Oncology|February 23, 2024
Therapeutic Strategies for Gliomas Associated With Cancer Predisposition SyndromesKeng Lam, Carlos Kamiya-Matsuoka, John M Slopis, et al.
Journal of Immunotherapy and Precision Oncology|May 22, 2023
Recent Therapeutic Advances in Pituitary CarcinomaIan J Robertson, Timothy A Gregory, Steven G Waguespack, et al.
Cancer|May 25, 2023
Characterization of industry relationships in oncologyRebecca A Harrison, Nazanin K Majd, Margaret O Johnson, et al.
Journal of Pediatric Hematology/Oncology|September 26, 2012
Total skin electron beam radiation in a pediatric patient with leukemia cutis: a case reportNazanin K Majd, Sheena K Jain, Mike C Murphy, et al.
Journal of Gastrointestinal Oncology|July 11, 2024
Intrathecal topotecan with systemic checkpoint inhibitor therapy for gastroesophageal cancer with leptomeningeal involvement: two case reports and review of the literatureCindy M Pabon, Debra N Yeboa, Barbara J O'Brien, et al.
Neuro-Oncology Advances|March 19, 2021
The promise of DNA damage response inhibitors for the treatment of glioblastomaNazanin K Majd, Timothy A Yap, Dimpy Koul, et al.
Pageof 4